State Street Corp Maxcyte, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Maxcyte, Inc. stock. As of the latest transaction made, State Street Corp holds 2,269,135 shares of MXCT stock, worth $9.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,269,135

Previous 2,158,069 5.15%

Holding current value

$9.69 Million

Previous $8.46 Million 4.34%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.68 - $5.06 $408,722 - $561,993	111,066 Added 5.15%	2,269,135 $8.83 Million
Q2 2024 Aug 14, 2024	BUY	$3.63 - $5.0 $626,338 - $862,725	172,545 Added 8.69%	2,158,069 $8.46 Million
Q1 2024 May 15, 2024	BUY	$3.94 - $5.38 $163,616 - $223,415	41,527 Added 2.14%	1,985,524 $8.32 Million
Q4 2023 Feb 14, 2024	BUY	$2.6 - $5.24 $269,939 - $544,032	103,823 Added 5.64%	1,943,997 $9.14 Million
Q3 2023 Nov 14, 2023	BUY	$3.02 - $5.1 $83,956 - $141,780	27,800 Added 1.53%	1,840,174 $5.74 Million
Q2 2023 Aug 14, 2023	BUY	$3.69 - $5.35 $67,250 - $97,503	18,225 Added 1.02%	1,812,374 $8.32 Million
Q1 2023 May 15, 2023	BUY	$4.03 - $5.89 $10,405 - $15,207	2,582 Added 0.14%	1,794,149 $8.88 Million
Q4 2022 Feb 14, 2023	BUY	$4.92 - $7.4 $221,685 - $333,429	45,058 Added 2.58%	1,791,567 $9.78 Million
Q3 2022 Nov 15, 2022	BUY	$4.52 - $6.51 $857,959 - $1.24 Million	189,814 Added 12.19%	1,746,509 $11.4 Million
Q2 2022 Aug 15, 2022	SELL	$3.59 - $6.81 $21,773 - $41,302	-6,065 Reduced 0.39%	1,556,695 $7.36 Million
Q1 2022 May 16, 2022	BUY	$5.26 - $10.84 $1.33 Million - $2.73 Million	252,201 Added 19.24%	1,562,760 $10.9 Million
Q4 2021 Feb 14, 2022	BUY	$8.87 - $12.94 $10.8 Million - $15.8 Million	1,219,183 Added 1334.25%	1,310,559 $13.4 Million
Q3 2021 Nov 15, 2021	BUY	$12.21 - $17.2 $1.12 Million - $1.57 Million	91,376 New	91,376 $1.12 Million

Others Institutions Holding MXCT

# of Institutions

124

Shares Held

65.6M

Call Options Held

Put Options Held

View Full List

About MAXCYTE, INC.

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $434M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

More about MXCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Maxcyte, Inc. Transaction History